Nuveen Asset Management, LLC Boston Scientific Corp Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 11,956,814 shares of BSX stock, worth $904 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

11,956,814

Previous 10,349,228 15.53%

Holding current value

$904 Million

Previous $598 Million 36.88%

% of portfolio

0.25%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$57.6 - $68.62 $92.6 Million - $110 Million	1,607,586 Added 15.53%	11,956,814 $819 Million
Q4 2023 Feb 14, 2024	BUY	$48.64 - $57.81 $38.3 Million - $45.5 Million	786,774 Added 8.23%	10,349,228 $598 Million
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $10.5 Million - $11.4 Million	208,515 Added 2.23%	9,562,454 $505 Million
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $65.8 Million - $72.3 Million	1,323,650 Added 16.48%	9,353,939 $506 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $52.5 Million - $58.2 Million	-1,163,413 Reduced 12.65%	8,030,289 $402 Million

Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $53.8 Million - $64.2 Million	-1,359,226 Reduced 12.88%	9,193,702 $425 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $38 Million - $114 Million	1,036,331 Added 10.89%	10,552,928 $409 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $4.44 Million - $5.93 Million	125,891 Added 1.34%	9,516,597 $355 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $82.7 Million - $91.2 Million	2,021,204 Added 27.43%	9,390,706 $416 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $42.2 Million - $49.7 Million	-1,107,831 Reduced 13.07%	7,369,502 $313 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $82.8 Million - $92.2 Million	-2,009,244 Reduced 19.16%	8,477,333 $368 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $138 Million - $158 Million	-3,580,303 Reduced 25.45%	10,486,577 $448 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $17.6 Million - $19.7 Million	-497,649 Reduced 3.42%	14,066,880 $544 Million
Q4 2020 May 17, 2021	SELL	$33.15 - $41.97 $2.34 Million - $2.97 Million	-70,695 Reduced 0.48%	14,564,529 $524 Million
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $272 Million - $344 Million	-8,199,473 Reduced 35.91%	14,635,224 $526 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $53.7 Million - $65.8 Million	1,559,242 Added 7.33%	22,834,697 $873 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $22.1 Million - $28.7 Million	733,415 Added 3.57%	21,275,455 $747 Million
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $204 Million - $362 Million	7,914,016 Added 62.67%	20,542,040 $670 Million
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $64.2 Million - $76.9 Million	1,693,953 Added 15.49%	12,628,024 $571 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $86.1 Million - $92.8 Million	2,136,455 Added 24.28%	10,934,071 $445 Million
Q2 2019 Aug 15, 2019	BUY	$34.91 - $42.98 $302 Million - $372 Million	8,645,002 Added 5664.62%	8,797,616 $378 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $121,898 - $150,938	-3,704 Reduced 2.37%	152,614 $5.86 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $33,570 - $41,304	-1,058 Reduced 0.67%	156,318 $5.52 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $6,730 - $7,919	205 Added 0.13%	157,376 $6.06 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $1.85 Million - $2.37 Million	68,994 Added 78.24%	157,171 $5.14 Million
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $223,448 - $253,064	-8,867 Reduced 9.14%	88,177 $2.41 Million
Q4 2017 Feb 14, 2018	SELL	$24.79 - $29.8 $4.04 Million - $4.86 Million	-163,126 Reduced 62.7%	97,044 $0
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $6.83 Million - $7.59 Million	260,170	260,170 $7.59 Million

Others Institutions Holding BSX

# of Institutions

1,319

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $108B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Boston Scientific Corp Transaction History